Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
Purpose Dupilumab is a widely recommended treatment for moderate-to-severe atopic dermatitis (AD), with known ocular side effects but less frequent cutaneous reactions.Material and methods This case report details a 52-year-old female patient with atopic
C. Grote+3 more
doaj +1 more source
Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis
Objective: Eosinophilic Otitis Media (EOM) is an intractable disease caused by type 2 inflammation, such as Eosinophilic Chronic Rhinosinusitis (ECRS) and bronchial asthma. Biologics have recently been used to treat ECRS and bronchial asthma.
Seiichiro Kamimura+6 more
doaj
Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia–Pacific Region
Asthma prevalence is increasing in the Asia–Pacific region, and this population is frequently underrepresented in phase 3 clinical studies. We demonstrate Dupilumab's efficacy and safety among patients with uncontrolled moderate‐to‐severe type 2 asthma.
Qingling Zhang+13 more
wiley +1 more source
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message [PDF]
Angelo Armandi+6 more
openalex +1 more source
Algorithms in Allergy: Diagnosis and Treatment of Atopic Dermatitis Complicated by Eczema Herpeticum
Allergy, EarlyView.
Stephan Traidl+2 more
wiley +1 more source
Circulating Food Allergen‐Specific Antibodies, Beyond IgG4, Are Elevated in Eosinophilic Esophagitis
Elevated IgG and IgA subclasses to food allergens in eosinophilic esophagitis (EoE) highlight a complex immune response involving antibody production, underscoring the significance of dietary triggers like cow's milk in disease management and potential for personalised therapies.
Manal Bel Imam+46 more
wiley +1 more source
A case of recurrent chronic eosinophilic pneumonia after switching from benralizumab to dupilumab
Dupilumab inhibits interleukin-4Rα and suppresses type 2 inflammation. Careful administration of dupilumab is required because it increases the blood eosinophil count secondary to a decrease in local eosinophil counts, sometimes resulting in eosinophilic
Daiki Nakashima+2 more
doaj
Dupilumab as therapeutic option in polysensitized atopic dermatitis patients suffering from food allergy [PDF]
IgE-mediated food allergy is characterized immunologically by a type 1 immune response triggered upon exposure to specific foods and clinically by a broad range of manifestations and variable severity.
Amore E.+12 more
core +2 more sources
Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study [PDF]
William W. Busse+12 more
openalex +1 more source